Current Assets 更改
Adcock Ingram Holdings ZAR 4.69B 76.51M 2023-12
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Celltrion KRW 362.37B 4.65T 2024-03
Cspc Pharmaceutical CNY 26.74B 2.36B 2023-12
Dianthus Therapeutics USD 380.93M 203.48M 2024-03
Ecofibre AUD 39.4M 17.77M 2023-12
Gilead Sciences USD 14.04B 2.41B 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Kangmei Pharma CNY 6.86B 164.51M 2024-03
Knight Therapeutics CAD 388.44M 23.33M 2024-03
Laboratorios Farma EUR 485.42M 23.92M 2024-03
MacroGenics USD 202.58M 48.76M 2024-03
Malin Corporation EUR 35.8M 3M 2023-12
Medical Developments International AUD 31.03M 11.73M 2023-12
Neuren Pharmaceuticals AUD 247.16M 150.76M 2023-12
Organigram Holdings CAD 194.26M 33.97M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Pharma Mar EUR 241.36M 11.24M 2024-03
Probiotec AUD 72.62M 3.05M 2023-12
Qiagen NV USD 1.89B 256.8M 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Sartorius EUR 2.78B 822.2M 2024-03
Sino Biopharmaceutical CNY 23.81B 3.17B 2023-12
Takeda JPY 2.43T 33.24B 2023-12
Tilray USD 631.21M 10.82M 2024-02
Zz Pientze Pharmaceu 14.13B 141.28M 2023-09



Avrobio 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.